OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
10,560
-290 (-2.67%)
At close: Mar 6, 2026
56.44% (1Y)
| Market Cap | 179.29B |
| Revenue (ttm) | 87.58B |
| Net Income (ttm) | 11.18B |
| Shares Out | 17.65M |
| EPS (ttm) | 731.00 |
| PE Ratio | 13.90 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 273,866 |
| Average Volume | 1,094,982 |
| Open | 10,850 |
| Previous Close | 10,850 |
| Day's Range | 10,240 - 11,180 |
| 52-Week Range | 5,610 - 14,040 |
| Beta | 0.66 |
| RSI | 54.41 |
| Earnings Date | Jan 23, 2026 |